ID

35516

Beschreibung

Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Stichworte

Versionen (1)
  1. 06.03.19 06.03.19 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

6. März 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)

Englisch

Study Medication and Compliance Record

1 Formulare  
Administrative data
Beschreibung

Administrative data

Alias
UMLS CUI-1
C1320722
Centre Number
Beschreibung

Study Coordinating Center, Identification number

Datentyp

integer

Alias
UMLS CUI [1,1]
C2825181
UMLS CUI [1,2]
C1300638
Patient Number
Beschreibung

Clinical Trial Subject Unique Identifier

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
Patient Initials
Beschreibung

Person Initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Study Medication Record
Beschreibung

Study Medication Record

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C2734539
Study Med. Week No.
Beschreibung

Experimental drug, Week, Numbers

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0439230
UMLS CUI [1,3]
C0237753
Is this a Dose Reduction?
Beschreibung

if ’No’, continue if ’Yes’, please complete theDose Reductions due to AE on page 64. Do not continue on this page for this visit.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
Dose Level (Specify 1 - 8)
Beschreibung

Experimental drug, Dosage, Level

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0441889
Date First Dose
Beschreibung

Experimental drug, Medication dose, Start Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3174092
UMLS CUI [1,3]
C0808070
Date Last Dose
Beschreibung

Experimental drug, Date last dose

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1762893
Number of tablets dispensed
Beschreibung

Experimental Drug, Dispensed Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C0805077
Number of tablets returned
Beschreibung

Experimental drug, Returned Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C2699071
Interruption of ≥ 2 consecutive days?
Beschreibung

Experimental drug, Interruption

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1512900
Medication Labels
Beschreibung

Experimental Drug, Drug Labeling

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0013191
Dose Reduction Due to Adverse Experiences
Beschreibung

Dose Reduction Due to Adverse Experiences

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1707814
UMLS CUI-3
C0877248
Study Med. Week No.
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Week, Numbers

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0439230
UMLS CUI [1,5]
C0237753
Dose Level (Specify 1 - 8)
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Dosage, Level

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0178602
UMLS CUI [1,5]
C0441889
Date First Dose
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Medication dose, Start Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C3174092
UMLS CUI [1,5]
C0808070
Date Last Dose
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Date last dose

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1762893
Number of tablets dispensed
Beschreibung

Experimental Drug, Dose Reduced, Adverse Event, Dispensed Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0805077
Number of tablets returned
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Returned Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C2699071
Interruption of ≥ 2 consecutive days?
Beschreibung

Experimental drug, Dose Reduced, Adverse Event, Interruption

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1512900
Medication Labels
Beschreibung

Experimental Drug, Dose Reduced, Adverse Event, Drug Labeling

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0013191
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Study Medication and Compliance Record

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Study Coordinating Center, Identification number
Item
Centre Number
integer
C2825181 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
Clinical Trial Subject Unique Identifier
Item
Patient Number
integer
C2348585 (UMLS CUI [1])
Person Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Study Medication Record
C0304229 (UMLS CUI-1)
C2734539 (UMLS CUI-2)
Item
Study Med. Week No.
text
C0304229 (UMLS CUI [1,1])
C0439230 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
Experimental drug, Week, Numbers
Code List
Study Med. Week No.
CL Item
Wk 1 (Days 1-2) (1)
CL Item
Wk 1 (Days 3-7) (2)
CL Item
Wk 2 (3)
CL Item
Wk 3 (4)
CL Item
Wk 4 (5)
CL Item
Wk 5 (6)
CL Item
Wk 6 (7)
CL Item
Wk 7 (8)
CL Item
Wk 8 (9)
CL Item
Wk 9 (10)
CL Item
Wk 10 (11)
CL Item
Wk 11 (12)
CL Item
Wk 12 (13)
Experimental drug, Dose Reduced
Item
Is this a Dose Reduction?
boolean
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
Experimental drug, Dosage, Level
Item
Dose Level (Specify 1 - 8)
integer
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0441889 (UMLS CUI [1,3])
Experimental drug, Medication dose, Start Date
Item
Date First Dose
date
C0304229 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Experimental drug, Date last dose
Item
Date Last Dose
date
C0304229 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
Experimental Drug, Dispensed Amount
Item
Number of tablets dispensed
integer
C0805077 (UMLS CUI [1,1])
C0805077 (UMLS CUI [1,2])
Experimental drug, Returned Amount
Item
Number of tablets returned
integer
C2699071 (UMLS CUI [1,1])
C2699071 (UMLS CUI [1,2])
Experimental drug, Interruption
Item
Interruption of ≥ 2 consecutive days?
boolean
C0304229 (UMLS CUI [1,1])
C1512900 (UMLS CUI [1,2])
Experimental Drug, Drug Labeling
Item
Medication Labels
text
C0304229 (UMLS CUI [1,1])
C0013191 (UMLS CUI [1,2])
Item Group
Dose Reduction Due to Adverse Experiences
C0304229 (UMLS CUI-1)
C1707814 (UMLS CUI-2)
C0877248 (UMLS CUI-3)
Experimental drug, Dose Reduced, Adverse Event, Week, Numbers
Item
Study Med. Week No.
text
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0439230 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Dosage, Level
Item
Dose Level (Specify 1 - 8)
integer
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C0441889 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Medication dose, Start Date
Item
Date First Dose
date
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C3174092 (UMLS CUI [1,4])
C0808070 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Date last dose
Item
Date Last Dose
date
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1762893 (UMLS CUI [1,4])
Experimental Drug, Dose Reduced, Adverse Event, Dispensed Amount
Item
Number of tablets dispensed
integer
C0805077 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Dose Reduced, Adverse Event, Returned Amount
Item
Number of tablets returned
integer
C2699071 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Dose Reduced, Adverse Event, Interruption
Item
Interruption of ≥ 2 consecutive days?
boolean
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1512900 (UMLS CUI [1,4])
Experimental Drug, Dose Reduced, Adverse Event, Drug Labeling
Item
Medication Labels
text
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0013191 (UMLS CUI [1,4])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video